In the morning of April 3, 2019, Professor Ming-Wei Wang, Director of the National Center for Drug Screening/Chinese National Compound Library, visited Sorrento Therapeutics, Inc. (NASDAQ: SRNE) in San Diego, California, U.S.A. He was warmly received by Drs. Henry (Hongjun) Ji (Chief Executive Officer), Hui Li (Senior Vice President, Business Development) and Gunnar F. Kaufman (Senior Vice President, Research and Global Partnerships). They conducted an in-depth and productive discussion about setting up collaboration in high-throughput screening of small molecule ligands against a specified G protein-coupled receptor.